Brain Tumor Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Brain Dead Diagnosis and Treatment Market Trends and the market is segmented by Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others), Tumor Type (Metastatic, Meningioma, Glioblastoma, Pituitary Endoma, and Others), End User (Hospitals, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Brain Tumor Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Brain Tumor Diagnostics Market Size

Brain Tumor Diagnostics Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 2.46 Billion
Market Size (2030) USD 3.66 Billion
CAGR (2025 - 2030) 8.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Brain Tumor Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Brain Tumor Diagnostics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Brain Tumor Diagnostics Market Analysis

The Brain Tumor Diagnostics Market size is estimated at USD 2.46 billion in 2025, and is expected to reach USD 3.66 billion by 2030, at a CAGR of 8.3% during the forecast period (2025-2030).

The COVID-19 pandemic had a major impact on the brain tumor diagnostics market. Diagnostic procedures were postponed at the beginning of the pandemic as the hospitals and surgeons were advised to postpone or cancel elective procedures. For instance, according to the study published by Computational and Structural Biotechnology Journal in January 2021, malignant juvenile brain tumors are known for their rapid growth, necessitating early detection and treatment. As a result, delaying diagnosis may damage its effectiveness, lowering patient survival rates. This has further impacted the growth of the brain tumor diagnostics market during the pandemic.

Moreover, Brain Tumor Research, a research organization, reported a drastic delay in the diagnosis and treatment approaches, such as chemotherapy and radiotherapy for different types of brain tumors. However, the market is gradually stabilizing as COVID-19 cases are declining, resulting in the return of the normal demand levels for brain tumor diagnostics. Thus, COVID-19 is expected to significantly impact the brain tumor diagnostics market over the forecast period.

Factors such as the increasing prevalence of neurological disorders and cancers and the rising number of smokers are expected to drive the growth of the market over the forecast period. For instance, according to the estimates of the American Cancer Society, in 2023, about 24,810 malignant tumors of the brain or spinal cord will be diagnosed in the United States. This increase in cancer cases is expected to drive the overall brain tumor diagnostics market. Glioblastoma is an aggressive form of a brain tumor which occurs mostly in adults. It can also occur in children, but very rarely. It grows fast and spreads quickly. Quick diagnosis and treatment are necessary, as it is a fatal disorder.

Moreover, there is a rising prevalence of brain cancer across the world. For instance, according to an article published by netmed.com, in June 2022, around 330,000 children and adults globally were diagnosed with cancer of the Central Nervous System in a year. In India, central nervous system (CNS) cancer ranges from 5 to 10 per 100,000 people, with a rising trend and accounts for 2% of cancer. Thus, the increasing prevalence of brain tumors is one of the major factors augmenting the growth of the market.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However, high cost associated with diagnosis are projected to hamper the market growth slightly over the forecast period.

Brain Tumor Diagnostics Industry Overview

The brain tumor diagnostics market is consolidated in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known,, including GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Fujifilm Corporation, and Hitachi, Ltd, among others.

Brain Tumor Diagnostics Market Leaders

  1. GE Healthcare

  2. Koninklijke Philips N.V.

  3. Siemens Healthcare GmbH

  4. Fujifilm Corporation

  5. Hitachi, Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Brain Tumor Diagnostics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Brain Tumor Diagnostics Market News

  • February 2023: Roche announced the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody to identify mutation status in patients diagnosed with brain cancer.
  • In January 2023: Datar Cancer Genetics Inc. received FDA breakthrough device designation for the TriNetra-Glio blood test to help in the diagnosis of brain tumors.

Brain Tumor Diagnostics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Neurological Disorders and Cancers
    • 4.2.2 Rising Number of Smokers
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated with Diagnosis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Diagnostic Type
    • 5.1.1 Imaging Test
    • 5.1.1.1 MRI
    • 5.1.1.2 CT Scan
    • 5.1.1.3 Other
    • 5.1.2 Lumbar Puncture
    • 5.1.3 Biopsy
    • 5.1.4 Molecular Testing
    • 5.1.5 Others
  • 5.2 By Tumor Type
    • 5.2.1 Metastatic
    • 5.2.2 Meningioma
    • 5.2.3 Glioblastoma
    • 5.2.4 Pituitary Endoma
    • 5.2.5 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostics Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Koninklijke Philips N.V.
    • 6.1.3 Siemens Healthineers
    • 6.1.4 Fujifilm Corporation
    • 6.1.5 Hitachi, Ltd.
    • 6.1.6 Hologic, Inc.
    • 6.1.7 NantOmics
    • 6.1.8 Thermo Fisher Scientific
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Brain Tumor Diagnostics Industry Segmentation

As per the scope of the report, a brain tumor is an abnormal growth of cells in or around your brain. The diagnosis of a brain tumor involves a physical exam, neurological exam, imaging of the brain or spine (depending on the patient's symptoms), and a specific biopsy based on the location of the tumor. 

The brain tumor diagnostics market is segmented by diagnostic type (imaging test, lumbar puncture, biopsy, molecular testing, and others), tumor type (metastatic, meningioma, glioblastoma, pituitary adenoma, and others), end user (hospitals, diagnostics centers, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD) for the above segments.

By Diagnostic Type Imaging Test MRI
CT Scan
Other
Lumbar Puncture
Biopsy
Molecular Testing
Others
By Tumor Type Metastatic
Meningioma
Glioblastoma
Pituitary Endoma
Others
By End User Hospitals
Diagnostics Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Brain Tumor Diagnostics Market Research FAQs

How big is the Brain Tumor Diagnostics Market?

The Brain Tumor Diagnostics Market size is expected to reach USD 2.46 billion in 2025 and grow at a CAGR of 8.30% to reach USD 3.66 billion by 2030.

What is the current Brain Tumor Diagnostics Market size?

In 2025, the Brain Tumor Diagnostics Market size is expected to reach USD 2.46 billion.

Who are the key players in Brain Tumor Diagnostics Market?

GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Fujifilm Corporation and Hitachi, Ltd. are the major companies operating in the Brain Tumor Diagnostics Market.

Which is the fastest growing region in Brain Tumor Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Brain Tumor Diagnostics Market?

In 2025, the North America accounts for the largest market share in Brain Tumor Diagnostics Market.

What years does this Brain Tumor Diagnostics Market cover, and what was the market size in 2024?

In 2024, the Brain Tumor Diagnostics Market size was estimated at USD 2.26 billion. The report covers the Brain Tumor Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Brain Tumor Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Brain Dead Diagnosis and Treatment Industry Report

Statistics for the 2025 Brain Tumor Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Brain Tumor Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Brain Dead Diagnosis and Treatment Market Report Snapshots